Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von JREMY 

CME Group Inc. diskutieren

CME Group Inc.

WKN: A0MW32 / Symbol: CME / Name: CME Group / Aktie / Investment Banking & Finanzdienstleistungen / Large Cap /

233,20 €
-0,13 %

Einschätzung Buy
Rendite (%) 2,09 %
Kursziel 267,73
Veränderung
Endet am 24.04.26

CME Group Inc. (NASDAQ: CME) had its price target raised by analysts at Morgan Stanley from $301.00 to $304.00. They now have an "overweight" rating on the stock.
Ratings data for CME provided by MarketBeat

Einschätzung Buy
Rendite (%) 1,54 %
Kursziel 268,83
Veränderung
Endet am 25.04.26

CME Group Inc. (NASDAQ: CME) had its price target raised by analysts at UBS Group AG from $290.00 to $305.00. They now have a "buy" rating on the stock.
Ratings data for CME provided by MarketBeat

Einschätzung Buy
Rendite (%) -3,50 %
Kursziel 263,46
Veränderung
Endet am 04.06.26

CME Group Inc. (NASDAQ: CME) had its price target raised by analysts at Oppenheimer Holdings Inc. from $282.00 to $300.00. They now have an "outperform" rating on the stock.
Ratings data for CME provided by MarketBeat

CME Group Inc. (NASDAQ: CME) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "sell" rating.
Ratings data for CME provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,21 %
Kursziel 253,67
Veränderung
Endet am 15.07.26

CME Group Inc. (NASDAQ: CME) had its price target raised by analysts at Piper Sandler from $283.00 to $296.00. They now have an "overweight" rating on the stock.
Ratings data for CME provided by MarketBeat

Einschätzung Buy
Rendite (%) -0,04 %
Kursziel 257,34
Veränderung
Endet am 24.07.26

CME Group Inc. (NASDAQ: CME) had its price target raised by analysts at Oppenheimer Holdings, Inc. from $300.00 to $303.00. They now have an "outperform" rating on the stock.
Ratings data for CME provided by MarketBeat

Einschätzung Sell
Rendite (%) 3,05 %
Kursziel 214,60
Veränderung
Endet am 25.09.26

CME Group (NASDAQ:CME) had its price target raised by analysts at JPMorgan Chase & Co. from $246.00 to $252.00. They now have an "underweight" rating on the stock.
Ratings data for CME provided by MarketBeat

Einschätzung Buy
Rendite (%) 3,05 %
Kursziel 255,48
Veränderung
Endet am 25.09.26

CME Group (NASDAQ:CME) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $300.00 price target on the stock, up previously from $275.00.
Ratings data for CME provided by MarketBeat

Einschätzung Buy
Rendite (%) 3,44 %
Kursziel 265,76
Veränderung
Endet am 01.10.26

CME Group (NASDAQ:CME) was given a new $312.00 price target on by analysts at Morgan Stanley. They now have an "overweight" rating on the stock.
Ratings data for CME provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,86 %
Kursziel 262,81
Veränderung
Endet am 10.10.26

CME Group (NASDAQ:CME) had its price target lowered by analysts at Jefferies Financial Group Inc. from $313.00 to $304.00. They now have a "buy" rating on the stock.
Ratings data for CME provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,36 %
Kursziel 264,20
Veränderung
Endet am 13.10.26

CME Group (NASDAQ:CME) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc.. They now have a $307.00 price target on the stock.
Ratings data for CME provided by MarketBeat

Einschätzung Sell
Rendite (%) -0,45 %
Kursziel 221,24
Veränderung
Endet am 14.10.26

CME Group (NASDAQ:CME) had its price target raised by analysts at JPMorgan Chase & Co. from $252.00 to $256.00. They now have an "underweight" rating on the stock.
Ratings data for CME provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,43 %
Kursziel 258,57
Veränderung
Endet am 23.10.26

CME Group (NASDAQ:CME) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating. They now have a $300.00 price target on the stock, up previously from $266.00.
Ratings data for CME provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,11 %
Kursziel 270,64
Veränderung
Endet am 23.10.26

CME Group (NASDAQ:CME) had its price target raised by analysts at Morgan Stanley from $312.00 to $314.00. They now have an "overweight" rating on the stock.
Ratings data for CME provided by MarketBeat

Einschätzung Sell
Rendite (%) 0,11 %
Kursziel 226,68
Veränderung
Endet am 23.10.26

CME Group (NASDAQ:CME) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $262.00 to $263.00. They now have a "sell" rating on the stock.
Ratings data for CME provided by MarketBeat

Einschätzung Buy
Rendite (%) -4,77 %
Kursziel 270,09
Veränderung
Endet am 13.11.26

CME Group (NASDAQ:CME) had its price target raised by analysts at Piper Sandler from $296.00 to $313.00. They now have an "overweight" rating on the stock.
Ratings data for CME provided by MarketBeat

Einschätzung Buy
Rendite (%) -3,91 %
Kursziel 266,45
Veränderung
Endet am 14.11.26

CME Group (NASDAQ:CME) had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $300.00 to $310.00. They now have a "buy" rating on the stock.
Ratings data for CME provided by MarketBeat

Einschätzung Sell
Rendite (%) -2,31 %
Kursziel 229,02
Veränderung
Endet am 25.11.26

CME Group (NASDAQ:CME) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $263.00 to $264.00. They now have a "sell" rating on the stock.
Ratings data for CME provided by MarketBeat

Einschätzung Sell
Rendite (%) 0,13 %
Kursziel 225,68
Veränderung
Endet am 05.12.26

CME Group (NASDAQ:CME) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $264.00 to $263.00. They now have a "sell" rating on the stock.
Ratings data for CME provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,50 %
Kursziel 270,71
Veränderung
Endet am 17.12.26

CME Group (NASDAQ:CME) had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $310.00 to $318.00. They now have a "buy" rating on the stock.
Ratings data for CME provided by MarketBeat